Approach
Team
Portfolio
Creating Value
Purpose and Values
Latest News
Get in Touch
Join us on LinkedIn
Copyright ©
Terms & Conditions
Privacy
Investor Portal
Select An Option Below to Login
NRV, NRF III and NRF IV
KNRV II
Approach
Team
Portfolio
Creating Value
Return to News
Diagnostics Market Outlook and How the FDA’s Fast Tracked Approval Process Has Helped Companies Like NOWDiagnostics
March 28, 2025
Up Next
April 8, 2025
Optilogic Closes $40M Series B
Read More